Review articleSerious infections due to methicillin-resistant Staphylococcus aureus: An evolving challenge for physicians
Introduction
Since the apparition of methicillin resistance of Staphylococcus aureus in 1961, methicillin-resistant staphylococci have become widespread in hospitals around the world, and nowadays represent the most common causes of bacterial nosocomial infection [1]. In the past, acquisition of methicillin-resistant staphylococci colonization or infection was generally considered to be restricted to the nosocomial setting. In the last decade the epidemiology of staphylococcal infections has partially changed [2] as a consequence of two major factors: 1) the increasing number of outpatients with extensive health-care contact, and 2) the emergence of community-acquired (CA) clones of methicillin-resistant staphylococci. Because of that, an increasing prevalence of health-care-associated (HCA) [3] or CA infections has been registered both in the United States and Europe [4].
The changing epidemiology of methicillin-resistant staphylococcal infections is a cause for concern among physicians. The purposes of this article are, starting by the description of illustrative cases, to review the current state of knowledge regarding methicillin-resistant staphylococcal infections, to identify those factors which may help physicians to recognize the patients at high risk, and to manage these infections appropriately.
Section snippets
Illustrative case
A 59-year-old woman was admitted to the hospital because the onset of fever, obnubilation and dyspnoea. Her medical history was notable for a diagnosis of myelodisplastic syndrome, autoimmune haemolytic anemia, chronic B-related hepatitis, and diabetes mellitus type 2. Within the last three months the patient had multiple hospital admissions due to episodes of acute gastrointestinal bleeding. Seven days before admission the patient had a totally implantable central venous access device
Conclusions
During the last decade important changes in the epidemiology of infections due to MRSA have occurred. CA-MRSA infections represent a major cause of concern for physicians, who must consider this microbial etiology not only in cases of nosocomial acquisition but also in patients coming from the community without any risk factors for MRSA colonization or infection. Clinicians should recognize, on the basis of the presence of specific risk factors, those patients who have a high likelihood of
Learning points
- •
Methicillin-resistant S. aureus (MRSA), is not restricted to the nosocomial setting but is nowadays spreading in the community.
- •
The community spread of MRSA arises from two patient populations: patients with strains that have been acquired during an exposure to a health-care setting; patients with community-acquired strains, with few or no risk factors, including athletes, prisoners, and healthy children.
- •
Patients with health-care-associated-MRSA infections can be identified on the basis of
References (51)
- et al.
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)
Diagn Microbiol Infect Dis
(2004) - et al.
The clinical spectrum of Staphylococcus aureus pulmonary infection
Chest
(1990) - et al.
Epidemiology of methicillin-resistant staphylococci in Europe
Clin Microbiol Infect
(2003) New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission
Clin Microbiol Infect
(2006)- et al.
Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat
Lancet Infect Dis
(2005) - et al.
Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?
J Hosp Infect
(2001) - et al.
Association between Staphylococcus aureus carrying gene for Panton–Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients
Lancet
(2002) Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy
Clin Microbiol Infect
(2005)- et al.
Methicillin-resistant Staphylococcus aureus in an intensive care unit: a 10 year analysis
J Hosp Infect
(2007) - et al.
Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital
Diagn Microbiol Infect Dis
(2005)
Community-acquired methicillin-resistant Staphylococcus aureus infections
Int J Antimicrob Agents
Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?
Clin Microbiol Infect
Effect of antibiotics, alone and in combination, on Panton–Valentine leukocidin production by a Staphylococcus aureus reference strain
Clin Microbiol Infect
The need for new therapeutic agents: what is the pipeline?
Clin Microbiol Infect
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
Clin Infect Dis
The changing epidemiology of Staphylococcus aureus?
Emerg Infect Dis
Healthcare-associated infections in adults: a reason to change the accepted definition of community-acquired infections
Ann Intern Med
Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis
Ann Ital Med Intern
Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases
Arch Intern Med
Staphylococcus aureus bacteremia among elderly vs. younger adult patients: comparison of clinical features and mortality
Arch Intern Med
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
Clin Infect Dis
The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database
Arch Intern Med
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case–control study
Haematologica
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis
Clin Infect Dis
Bacteremic pneumonia due to Staphylococcus aureus: a comparison of diseases caused by methicillin-resistant and methicillin-susceptible organisms
Clin Infect Dis
Cited by (35)
Challenges in the management of chronic wound infections
2021, Journal of Global Antimicrobial ResistanceCitation Excerpt :Chronic wounds may be colonised or infected by healthcare-associated pathogens, including MRSA [71]. The spread of MRSA both in hospital and community settings represents a great challenge for clinicians [72,73]. The significance of S. aureus in a patient's wound needs to be assessed for each patient.
Diabetes and acute bacterial skin and skin structure infections
2021, Diabetes Research and Clinical PracticeCitation Excerpt :MRSA is not a challenge only for hospitalized patients. Community-acquired MRSA (CA-MRSA) is a predominant cause of purulent ABSSSIs and is particularly challenging because it may carry genes encoding the Panton-Valentine leucocidin associated with tissue necrosis and more severe disease presentation [28,29]. The prompt identification of patients presenting at ED with ABSSSIs at highest risk of CA-MRSA is crucial to prompt initiation of appropriate therapy.
Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model
2020, Journal of Microbiology, Immunology and InfectionAnatase TiO<inf>2</inf> co-doped with silver and ceria for antibacterial application
2018, Catalysis TodayTranscriptome analysis of methicillin-resistant Staphylococcus aureus in response to stigmasterol and lupeol
2017, Journal of Global Antimicrobial ResistanceLinezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy
2015, International Journal of Antimicrobial AgentsCitation Excerpt :Until recently, the glycopeptide antibiotics vancomycin and teicoplanin were effective options for the treatment of infections caused by meticillin-resistant Gram-positive pathogens. However, there have been numerous reports of strains with reduced susceptibility, or outright resistance, to glycopeptides, and evidence of a significant relationship between higher vancomycin minimum inhibitory concentrations (MICs), ranging between 1 mg/L and 2 mg/L, and treatment failure have led to calls for alternative therapies [4–7]. Linezolid is an important antimicrobial agent for the therapy of difficult-to-treat infections, especially pneumonia and skin and soft-tissue infections (SSTIs), caused by meticillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci.